LIST OF TABLES for the Biotechnology Report

Table 3.1: Time lag of companies from inception to first product commercialization
Table 3.2: Biotech new drugs approved in 2004
Table 3.3: Drugs approved for new indications
Table 3.4: Biotech drugs in pipeline according to therapeutic segments
Table 3.5: Patent expiration of major biotech drugs
Table 3.6: Selected diagnostic products approved in 2005
Table 5.1: Issues of biopiracy with some patents
Table 6.1: New Technologies, Companies and its Application During 2005
Table 7.1: Major companies in North America
Table 7.2: North American biotechnology clusters
Table 7.3: Major European companies
Table 7.4: The UK biotechnology clusters
Table 7.5: Major biotechnology companies
Table 8.1: Top 10 biotechnology companies, 2005
Table 8.2: Financials of Amgen (2003-2005)
Table 8.3 Top selling drugs (USDm), 2004-2005
Table 8.4: Financials of Genentech (2003-2005)
Table 8.5:  Top selling drugs (USDm), 2004-05
Table 8.6: Products of Genentech in various stages up to February 2006
Table 8.7: Financials of Genzyme (2003-2005)
Table 8.8:  Top selling drugs (USDm), 2004-2005
Table 8.9: Financials of Serono SA (2003-2005)
Table 8.10:  Top selling drugs (USDm), 2004-2005
Table 8.11: Financials of Biogen Idec Inc (2003-2005)
Table 8.12: Top selling drugs (USDm), 2004-2005
Table 8.13 Product Pipeline, Biogen Idec, as on March 2006
Table 8.14: Financials of Gilead (2003-2005)
Table 8.15: Top selling drugs (USDm), 2004-2005
Table 8.16 Financials (USDm) of Chiron, 2003-2005
Table 8.17: Top selling drugs (USDm), 2004-2005
Table 8.18 Financials of MedImmune, 2003-2005
Table 8.19: Top selling drugs (USDm), 2004-05
Table 8.20 Financials of Invitrogen, 2003-2005
Table 8.21: Revenue earnings, 2004-2005
Table 8.22 Financials of Millennium, 2003-2005
Table 8.23 Sales of Velcade in US, 2004-2005
Table 8.24 Products in different stages
Table 8.25 Financials of Monsanto, 2003-2005
Table 8.26: Biotechnology seeds of Monsanto
Table 8.27 Product Pipeline of Monsanto (As on March 2006)
Table 8.28 Financial results, 2003-2005
Table 8.29 Product sales in seeds segment (in USDm), 2004-2005
Table 10.1: Top 10 deals in recent years
Table 11.1: Noble Laureates as Founders of Biotechnology Farms